Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for Kombination aus einem Anti-CTLA4-Antikörper mit Etoposide für die synergistische Behandlung proliferativer Erkrankungen
Details for 2014162613
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2014162613
Title / Product Name
Kombination aus einem Anti-CTLA4-Antikörper mit Etoposide für die synergistische Behandlung proliferativer Erkrankungen
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2014162613
EP Publication Number
2769737
E-Number
881172
Language
EN
PCT Number
-
Publication Date
27.08.2014 A
05.04.2017 B1
Registration Date
05.04.2017
AT Publication Date
15.04.2017
Application Date
29.10.2009
Registration Number
-
Priorities
20.07.2009
US
226910 P
30.07.2009
US
462168
30.07.2009
WO
PCT/US2009/052209
IPC
A61K 45/06 20060101AFI20161103BHEP
Maximum Duration of Protection
29.10.2029
Owner
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543
US
Representative
Representative
Patentanwalt Mikšovsky KG
Bisamberger Straße 19
2100 Korneuburg
AT
Inventor
Lee, Francis, Y.
c/o Bristol-Myers Squibb Company Route 206 & Province Line Road
Princeton, NJ New Jersey 08543
US
Jure-Kunkel, Maria
c/o Bristol-Myers Squibb Company Route 206 & Province Line Road
Princeton, NJ New Jersey 08543
US
Information about Fees
Click here to load the fees